CreditReports.dk
HomeScreen companies

Forward Pharma Operations ApS Financials, key figures and credit report

CVR number: 38757504 Established 2017 Industry: 72 Scientific research and development
Company contact details
Strandvejen 125, 2900 Hellerup
Net sales 99.1 kDKK FY 2024 -81.9% vs 2023
EBIT margin -2 273.4 % FY 2024 -1,845.3 pp vs 2023
Net debt 64 400.9 kDKK FY 2024 +3,464.7% vs 2023
Quick ratio 5.0 FY 2024 -8.1 vs 2023

Company information

Official name
Forward Pharma Operations ApS
Established
2017
Company form
Private limited company
Industry

Data sources and methodology

The information about Forward Pharma Operations ApS combines official Danish company and financial-statement data with indicators calculated by Valuatum Oy.

Company information

Name, CVR number, address, industry and legal form are based on the Danish Central Business Register (CVR).

CVR / Virk

Annual accounts

Financial figures come from annual reports published through the Danish Business Authority. The latest financial year used is 2024.

Open the 2024 annual report

Key figures and credit risk

Valuatum Oy calculates financial ratios, comparisons and credit-risk indicators from the available accounts. The results support analysis and do not constitute a standalone credit decision.

Valuatum Oy

About Forward Pharma Operations ApS

Forward Pharma Operations ApS (CVR number: 3875750-4) is a company from KØBENHAVN. The company reported a net sales of 0.1 mDKK in 2024, demonstrating a decline of -81.9 % compared to the previous year. The operating profit percentage was poor at -2273.4 % (EBIT: -2.3 mDKK), while net earnings were -68.3 mDKK. The profitability of the company measured by Return on Assets (ROA) was -20.9 %, which can be considered poor and Return on Equity (ROE) was -24.4 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 80.1 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. Forward Pharma Operations ApS's liquidity measured by quick ratio was 5 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.

Financial information

See financials

Net sales (kDKK)

EBIT (kDKK)

Profitability

Solidity

Key figures (kDKK)

See financials
2020
2021
2022
2023
2024
Volume
Net sales351.02621.56724.02546.9599.13
Gross profit-8 158.31-9 004.41-7 895.22-2 341.60-2 253.59
EBIT-8 158.31-9 004.41-7 895.22-2 341.60-2 253.59
Net earnings-10 108.94-9 486.97-27 022.411 043.21-68 343.76
Shareholders equity total314 592.32305 105.35278 082.93279 126.14280 041.15
Balance sheet total (assets)337 159.16327 106.72305 108.79302 113.74349 446.71
Net debt- 199 538.71- 188 692.05- 179 998.75-1 914.0464 400.94
Profitability
EBIT-%-2 324.1 %-1 448.7 %-1 090.5 %- 428.1 %-2 273.4 %
ROA-2.1 %-2.3 %-8.3 %0.5 %-20.9 %
ROE-3.2 %-3.1 %-9.3 %0.4 %-24.4 %
ROI-2.1 %-2.3 %-8.3 %0.5 %-20.9 %
Economic value added (EVA)-25 570.01-25 942.19-24 329.15-17 653.19-17 350.76
Solvency
Equity ratio93.3 %93.3 %91.1 %92.4 %80.1 %
Gearing7.1 %7.2 %9.6 %8.0 %24.7 %
Relative net indebtedness %-56 819.4 %-30 347.7 %-24 805.7 %- 248.9 %65 116.2 %
Liquidity
Quick ratio14.114.011.313.15.0
Current ratio14.114.011.313.15.0
Cash and cash equivalents222 016.51210 630.06206 623.9324 348.844 857.83
Capital use efficiency
Trade debtors turnover (days)
Net working capital %84 080.3 %45 959.7 %38 402.8 %51 033.0 %282 507.4 %

Variable visualization

ROA FY 2024
-20.9%
Rating 0/100
-20%
0%
4%
11%
24%
60%
Graph showing the distribution of the variable
Equity ratio FY 2024
80.1%
Rating 59/100
-1%
21%
50%
81%
99%
100%
Graph showing the distribution of the variable

Credit Risk Report

Affordable credit risk report
for basic company risk checks.

Check the creditworthiness of Forward Pharma Operations ApS before offering payment terms. The report combines financial figures, risk scores, credit rating, bankruptcy risk and a credit-limit recommendation in one PDF.

AI Credit Risk Report

The core credit-risk figures,
explained with AI.

The AI Credit Risk Report contains the same core financial figures and risk measures as the Credit Risk Report. It also provides written analysis of the company's finances, risks, repayment capacity and assets, together with relevant context from web searches.

  1. 01 Includes the same financial figures, risk scores, credit rating and bankruptcy risk as the Credit Risk Report.
  2. 02 AI complements the analysis with web searches and brings in the relevant company and operating-environment observations.
  3. 03 The written analysis is more precise, more readable and better suited to decision-making.
€3 / report

Company-specific, AI-assisted credit risk report in PDF format.

For larger customers

Reports can be tailored to your own credit process: content structure, peer groups, risk thresholds, delivery method and AI-analysis weightings can all be adapted to your needs.
Ask about a tailored solution: contact@creditreports.dk

The report is intended for an initial financial assessment. · The final credit decision and any further verification are always the user's responsibility. · One-time payment, no subscription.

What the report includes

8 sections
Financial figures
Risk scores
Credit rating
Bankruptcy risk
AI web-search highlights
Written risk analysis
Conclusions
Ratio appendices

Companies in the same industry

Page generated